Announce Date | 05/12/2025 |
EPS Normalized Actual | $-0.59 (Miss by $-0.03) |
EPS GAAP Actual | $-0.59 (Miss by $-0.03) |
Revenue Actual | $0.1032B |
Revenue Surprise | Beat by $103.2M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.06 |
EPS GAAP Estimate | $-0.06 |
Revenue Estimate | $0.11585B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | -0.53 | -39.78 | -0.53812 | -0.52448 | 1 |
Dec 2025 | -0.53 | -39.78 | -1.41 | 0.15 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -1.81 | -1.72 | 0.1032B | -7.27% | -26.2M |
FQ4 2024 (Dec 2024) | -0.72 | -0.54 | 0.1099B | -8.55% | 2.9M |
FQ3 2024 (Sep 2024) | -0.22 | -0.04667 | 0.1139B | 100% | 1.9M |
FQ2 2024 (Jun 2024) | -2.49 | -3.83259 | 0.118B | 100% | -133.3M |
FQ1 2024 (Mar 2024) | -1.27 | -1.27 | 0.1107B | 100% | 110.7M |
FQ4 2023 (Dec 2023) | -0.83 | -0.83 | 0.1193B | 100% | 119.3M |
FQ1 2013 (Mar 2013) | 0 | 0 | 0.656B | 100% | 656M |
FQ2 2013 (Jun 2013) | 0 | 0 | 0.65B | 100% | 650M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.06
Consensus Revenue Estimates
0.11585B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -0.17 | -- | -0.1742 | -0.1658 | 1 |
FQ3 2026 (Sep 2026) | -0.12 | -- | -0.12297 | -0.11703 | 1 |
FQ2 2026 (Jun 2026) | -0.16 | -- | -0.16395 | -0.15605 | 1 |
FQ1 2026 (Mar 2026) | -0.34 | -432.35 | -0.3484 | -0.3316 | 1 |
FQ4 2025 (Oct 2025) | -0.015 | -4700 | -0.01591673 | -0.01427361 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.09B | -- | 0.09B | 0.09B | 1 |
FQ3 2026 (Sep 2026) | 0.09B | -- | 0.09B | 0.09B | 1 |
FQ2 2026 (Jun 2026) | 0.09B | -- | 0.09B | 0.1B | 1 |
FQ1 2026 (Mar 2026) | 0.1B | -7.57 | 0.09B | 0.1B | 1 |
FQ4 2025 (Oct 2025) | 0.11B | 0.5 | 0.11B | 0.12B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
6
EPS # of in-lines
2
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.09 | -1.81 | -1.72 | 95.03% |
FQ4 2024 (Dec 2024) | -0.18 | -0.72 | -0.54 | 75% |
FQ3 2024 (Sep 2024) | -0.17333 | -0.22 | -0.04667 | 21.21% |
FQ2 2024 (Jun 2024) | 1.34259 | -2.49 | -3.83259 | 153.92% |
FQ1 2024 (Mar 2024) | -1.27 | -1.27 | 100% | |
FQ4 2023 (Dec 2023) | -0.83 | -0.83 | 100% | |
FQ1 2013 (Mar 2013) | 0 | 0 | NAN% | |
FQ2 2013 (Jun 2013) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.13B | $0.1B | $-26.2M | -25.39% |
FQ4 2024 (Dec 2024) | $0.11B | $0.11B | $2.9M | 2.64% |
FQ3 2024 (Sep 2024) | $0.11B | $0.11B | $1.9M | 1.67% |
FQ2 2024 (Jun 2024) | $0.25B | $0.12B | $-133.3M | -112.97% |
FQ1 2024 (Mar 2024) | $0B | $0.11B | $110.7M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.12B | $119.3M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0.66B | $656M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.65B | $650M | 100% |